Trial intelligence / Profile preview

MEBO Dressing vs Standard Care for Skin Graft Sites

NCT02737943Phase 1Unknown

Sponsor
Zagazig University
Start
Mar 2016
Primary completion
Jun 2019
Modality
Botanical drug
Countries
1
01

Overview

Phase 1, randomised, single-blind trial of MEBO Moist Burn Ointment (2 arms), sponsored by Zagazig University. Primary endpoint: Wound Healing Assessment at 1 month. Status: unknown.

02

Drugs

MEBO Moist Burn Ointment

Beyond the preview

Go deeper on NCT02737943.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02737943.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call